Answers are grounded in this paper and cite their sources.
At clinically relevant dilutions of HTS, there is a paradoxical shortening of time to clot formation and increase in clot strength in vitro and no significant effects in a murine TBI model. However, with excess dilution, caution should be exercised when using serial HTS boluses in TBI patients at risk for trauma-induced coagulopathy.
No takes yet. Share an insight, caveat, or question.
Coleman et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: